GlaxoSmithKline to open global R&D center in Rockville
The GlaxoSmithKline company logo is seen on the GlaxoSmithKline Plc headquarters in London, U.K. The pharmaceutical giant announced Thursday it will located its U.S. vaccine research and development in Rockville. Pharmaceutical giant GlaxoSmithKline PLC will open a new global center for vaccine research and development in Rockville, the company announced Thursday .
Source: www.topix.net